Which principle places the rights, safety, and well-being of the trial subjects as the most important considerations, taking precedence over science and society?

• A. The rights, safety, and well-being of the trial subjects are the most important considerations and should prevail over interests of science and society.
• B. The scientific validity of the study is the primary concern.
• C. Regulatory compliance is the sole determinant of trial initiation.
• D. Sponsor's business goals determine trial conduct.

Answer: (A)

The key idea here is that protecting people who participate in research comes first. In ethical clinical research, the rights, safety, and well-being of trial subjects must prevail over any scientific or societal goals. This means study design should minimize risk, informed consent must be truly voluntary and informed, and ongoing safety monitoring is essential so that trials can be stopped or adjusted if risks outweigh potential benefits. The option that states these protections as the top priority matches this fundamental standard.

The other ideas—focusing primarily on scientific validity, treating regulatory compliance as the sole gatekeeper, or letting sponsor business goals drive conduct—do not align with this core ethical obligation, since they would subordinate participant welfare to other interests.